(TRS) TriMas - Overview
Stock: Dispensers, Closures, Fasteners, Cylinders, Engines
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.60% |
| Yield on Cost 5y | 0.49% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 97.0% |
| Payout Ratio | 9.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 28.1% |
| Relative Tail Risk | -6.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.25 |
| Alpha | 35.82 |
| Character TTM | |
|---|---|
| Beta | 0.855 |
| Beta Downside | 0.825 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.10% |
| CAGR/Max DD | 0.20 |
Description: TRS TriMas January 16, 2026
TriMas Corporation (NASDAQ: TRS) designs, manufactures, and sells a diversified portfolio of components for consumer packaging, aerospace, and industrial markets. It operates through three reporting segments-Packaging, Aerospace, and Specialty Products-leveraging brands such as Rieke, Monogram Aerospace Fasteners, and Norris Cylinder to serve OEMs, distributors, and end-users worldwide.
In FY 2023 the company generated roughly $1.3 billion in revenue, with the Packaging segment contributing about 55 % and the Aerospace segment delivering a higher-than-average operating margin (~9 %) thanks to defense-related contracts. The Specialty Products segment is sensitive to natural-gas production volumes, which have risen 4 % YoY amid higher commodity prices, supporting demand for Arrow-branded compressors and Norris gas cylinders.
Key macro drivers include (1) sustained consumer-goods spending that underpins dispenser and cap demand, (2) U.S. defense budget growth-projected to increase 3 % annually-fueling aerospace fastener orders, and (3) the rebound in industrial gas consumption as manufacturing output recovers from pandemic lows. These trends suggest that TriMas’s earnings are closely tied to broader economic cycles in packaging consumption, defense spending, and energy production.
For a deeper quantitative view of TRS’s valuation metrics, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 44.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 2.21 > 1.0 |
| NWC/Revenue: 29.90% < 20% (prev 31.04%; Δ -1.14% < -1%) |
| CFO/TA 0.07 > 3% & CFO 103.0m > Net Income 44.1m |
| Net Debt (421.3m) to EBITDA (159.6m): 2.64 < 3 |
| Current Ratio: 2.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (41.0m) vs 12m ago 0.14% < -2% |
| Gross Margin: 21.58% > 18% (prev 0.21%; Δ 2137 % > 0.5%) |
| Asset Turnover: 72.37% > 50% (prev 66.27%; Δ 6.09% > 0%) |
| Interest Coverage Ratio: 2.62 > 6 (EBITDA TTM 159.6m / Interest Expense TTM 36.1m) |
Altman Z'' 2.05
| A: 0.21 (Total Current Assets 483.2m - Total Current Liabilities 180.1m) / Total Assets 1.43b |
| B: 0.04 (Retained Earnings 55.1m / Total Assets 1.43b) |
| C: 0.07 (EBIT TTM 94.5m / Avg Total Assets 1.40b) |
| D: 0.08 (Book Value of Equity 57.0m / Total Liabilities 708.8m) |
| Altman-Z'' Score: 2.05 = BBB |
Beneish M -2.99
| DSRI: 1.05 (Receivables 192.1m/163.3m, Revenue 1.01b/906.5m) |
| GMI: 0.97 (GM 21.58% / 21.02%) |
| AQI: 0.96 (AQ_t 0.40 / AQ_t-1 0.41) |
| SGI: 1.12 (Revenue 1.01b / 906.5m) |
| TATA: -0.04 (NI 44.1m - CFO 103.0m) / TA 1.43b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of TRS shares?
Over the past week, the price has changed by +3.85%, over one month by +1.78%, over three months by +13.59% and over the past year by +50.66%.
Is TRS a buy, sell or hold?
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TRS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41.5 | 14.9% |
| Analysts Target Price | 41.5 | 14.9% |
| ValueRay Target Price | 41.2 | 14.1% |
TRS Fundamental Data Overview February 05, 2026
P/E Forward = 29.2398
P/S = 1.4001
P/B = 1.9582
P/EG = 1.63
Revenue TTM = 1.01b USD
EBIT TTM = 94.5m USD
EBITDA TTM = 159.6m USD
Long Term Debt = 407.1m USD (from longTermDebt, last quarter)
Short Term Debt = 9.64m USD (from shortTermDebt, last quarter)
Debt = 454.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 421.3m USD (from netDebt column, last quarter)
Enterprise Value = 1.84b USD (1.42b + Debt 454.9m - CCE 33.6m)
Interest Coverage Ratio = 2.62 (Ebit TTM 94.5m / Interest Expense TTM 36.1m)
EV/FCF = 41.47x (Enterprise Value 1.84b / FCF TTM 44.4m)
FCF Yield = 2.41% (FCF TTM 44.4m / Enterprise Value 1.84b)
FCF Margin = 4.38% (FCF TTM 44.4m / Revenue TTM 1.01b)
Net Margin = 4.35% (Net Income TTM 44.1m / Revenue TTM 1.01b)
Gross Margin = 21.58% ((Revenue TTM 1.01b - Cost of Revenue TTM 795.0m) / Revenue TTM)
Gross Margin QoQ = 23.06% (prev 24.00%)
Tobins Q-Ratio = 1.28 (Enterprise Value 1.84b / Total Assets 1.43b)
Interest Expense / Debt = 4.95% (Interest Expense 22.5m / Debt 454.9m)
Taxrate = 23.27% (2.82m / 12.1m)
NOPAT = 72.6m (EBIT 94.5m * (1 - 23.27%))
Current Ratio = 2.68 (Total Current Assets 483.2m / Total Current Liabilities 180.1m)
Debt / Equity = 0.63 (Debt 454.9m / totalStockholderEquity, last quarter 725.0m)
Debt / EBITDA = 2.64 (Net Debt 421.3m / EBITDA 159.6m)
Debt / FCF = 9.49 (Net Debt 421.3m / FCF TTM 44.4m)
Total Stockholder Equity = 698.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.15% (Net Income 44.1m / Total Assets 1.43b)
RoE = 6.31% (Net Income TTM 44.1m / Total Stockholder Equity 698.5m)
RoCE = 8.55% (EBIT 94.5m / Capital Employed (Equity 698.5m + L.T.Debt 407.1m))
RoIC = 6.51% (NOPAT 72.6m / Invested Capital 1.11b)
WACC = 7.79% (E(1.42b)/V(1.87b) * Re(9.07%) + D(454.9m)/V(1.87b) * Rd(4.95%) * (1-Tc(0.23)))
Discount Rate = 9.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.74%
[DCF Debug] Terminal Value 74.06% ; FCFF base≈31.5m ; Y1≈23.6m ; Y5≈14.2m
Fair Price DCF = N/A (negative equity: EV 276.4m - Net Debt 421.3m = -144.9m; debt exceeds intrinsic value)
EPS Correlation: -29.52 | EPS CAGR: -48.72% | SUE: -3.93 | # QB: 0
Revenue Correlation: 69.10 | Revenue CAGR: 6.99% | SUE: 0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.39 | Chg30d=-0.146 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=1.22 | Chg30d=-1.306 | Revisions Net=+2 | Growth EPS=-36.1% | Growth Revenue=-27.2%